incyte (INCY) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

incyte (INCY)

incyte (INCY) is covered by Stockchase stock experts. Read their latest opinions, ratings and top picks below.

124.64

-2.29 (1.80%)

as of Sep 23, 2026, 7:59:59 pm Market Open.

3 watching

BUY

Projected 19% earnings growth in 2026, yet trades at under 12x PE 2026. Has a robust drug pipeline.

DON'T BUY

The momentum has broken badly and has a high PE. But he entered this on a rebound that has momentum. Despite an upgrade today, he doesn't see a green light ahead.

Showing 1 to 2 of 2 entries

Most Recent Experts

John Zechner

J. Zechner & Assoc

Ernest Wong, Head of Research, Baskin Wealth Management

Baskin Wealth Management

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Joe Terranova

Virtus Investment Partners

Stephanie Link, Chief investment strategist, Hightower

Hightower

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

incyte (INCY) Frequently Asked Questions

What is incyte stock symbol?

incyte is a American stock, trading under the symbol INCY (previously INCY-Q on Stockchase) on the NASDAQ (INCY). It is usually referred to as NASDAQ:INCY or INCY

Is incyte a buy or a sell?

In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on INCY (previously INCY-Q on Stockchase). 1 analyst recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is BUY. Read the latest stock experts' ratings for incyte.

Is incyte a good investment or a top pick?

incyte was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for incyte.

Why is incyte stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for incyte.

Is incyte worth watching?

incyte is covered by Stockchase experts and is worth watching.

What is incyte stock price?

On 2026-09-23, incyte (INCY) stock closed at a price of $124.64.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].